A detailed history of Covington Capital Management transactions in Boston Scientific Corp stock. As of the latest transaction made, Covington Capital Management holds 1,525 shares of BSX stock, worth $149,709. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,525
Previous 1,468 3.88%
Holding current value
$149,709
Previous $55,000 7.27%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $2,092 - $6,250
57 Added 3.88%
1,525 $59,000
Q2 2022

Jul 08, 2022

SELL
$35.24 - $47.1 $3,488 - $4,662
-99 Reduced 6.32%
1,468 $55,000
Q3 2021

Nov 15, 2021

BUY
$41.23 - $45.88 $35,746 - $39,777
867 Added 123.86%
1,567 $68,000
Q2 2021

Aug 13, 2021

SELL
$38.58 - $44.24 $3,742 - $4,291
-97 Reduced 12.17%
700 $30,000
Q1 2021

May 14, 2021

BUY
$35.27 - $39.67 $775 - $872
22 Added 2.84%
797 $31,000
Q4 2020

Feb 16, 2021

BUY
$33.15 - $41.97 $2,486 - $3,147
75 Added 10.71%
775 $28,000
Q3 2020

Nov 16, 2020

SELL
$34.44 - $42.23 $34,440 - $42,230
-1,000 Reduced 58.82%
700 $27,000
Q1 2020

May 13, 2020

SELL
$25.83 - $45.71 $6,018 - $10,650
-233 Reduced 12.05%
1,700 $55,000
Q4 2019

Feb 18, 2020

BUY
$37.87 - $45.37 $8,823 - $10,571
233 Added 13.71%
1,933 $87,000
Q3 2019

Nov 18, 2019

SELL
$40.31 - $43.45 $26,403 - $28,459
-655 Reduced 27.81%
1,700 $69,000
Q2 2019

Aug 15, 2019

SELL
$34.91 - $42.98 $17,455 - $21,490
-500 Reduced 17.51%
2,355 $101,000
Q1 2019

May 15, 2019

BUY
$32.91 - $40.75 $5,101 - $6,316
155 Added 5.74%
2,855 $110,000
Q4 2018

Feb 15, 2019

BUY
$31.73 - $39.04 $63,460 - $78,080
2,000 Added 285.71%
2,700 $95,000
Q3 2018

Nov 15, 2018

SELL
$32.83 - $38.63 $10,374 - $12,207
-316 Reduced 31.1%
700 $27,000
Q3 2017

Nov 14, 2017

BUY
$26.26 - $29.17 $26,680 - $29,636
1,016
1,016 $30,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $141B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Covington Capital Management Portfolio

Follow Covington Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covington Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Covington Capital Management with notifications on news.